Suppr超能文献

肝脏微粒体中25-羟胆固醇的7α-羟基化作用。所涉及的酶不同于胆固醇7α-羟化酶的证据。

7 alpha hydroxylation of 25-hydroxycholesterol in liver microsomes. Evidence that the enzyme involved is different from cholesterol 7 alpha-hydroxylase.

作者信息

Toll A, Wikvall K, Sudjana-Sugiaman E, Kondo K H, Björkhem I

机构信息

Department of Pharmaceutical Biosciences, University of Uppsala, Sweden.

出版信息

Eur J Biochem. 1994 Sep 1;224(2):309-16. doi: 10.1111/j.1432-1033.1994.00309.x.

Abstract

Rat, pig and human liver microsomes were found to catalyze 7 alpha-hydroxylation of 25-hydroxycholesterol. In contrast to cholesterol 7 alpha-hydroxylase activity, the 7 alpha-hydroxylase activity towards 25-hydroxycholesterol in rat liver was not stimulated by cholestyramine treatment. After transfection with cDNA for human cholesterol 7 alpha-hydroxylase, COS cells showed a significant activity towards cholesterol but not towards 25-hydroxycholesterol. During purification of cholesterol 7 alpha-hydroxylase from pig liver microsomes, about 99% of the 7 alpha-hydroxylase activity towards 25-hydroxycholesterol and 27-hydroxycholesterol was clearly separated from 7 alpha-hydroxylase activity for cholesterol. The small amount of 25-hydroxycholesterol 7 alpha-hydroxylase activity retained in a partially purified preparation of cholesterol 7 alpha-hydroxylase was not inhibited by addition of cholesterol, indicating that the oxysterol binding site is different from the cholesterol binding site, presumely due to the presence of two different enzymes. It is concluded that different enzymes are involved in 7 alpha-hydroxylation of cholesterol and 7 alpha hydroxylation of side-chain-oxidized cholesterol in rat, pig and human liver. Inhibition experiments with a partially purified fraction of the oxysterol 7 alpha-hydroxylase from pig liver gave results consistent with the contention that the same enzyme is responsible for 7 alpha hydroxylation of both 25-hydroxycholesterol and 27-hydroxycholesterol. It has been suggested that cholesterol 7 alpha-hydroxylase can preferentially use oxysterols, in particular 25-hydroxycholesterol, as substrates and by this means inactivate important physiological regulators of cholesterol homeostasis. Such a mechanism would explain the unique property of the liver to resist down-regulation of the low-density-lipoprotein receptor [Dueland, S., Trawick, J.D., & Davies, R.A. (1993) J. Biol. Chem. 267, 22695-22698]. The present results do not support the contention that the important coupling between cholesterol 7 alpha-hydroxylase activity, the low-density-lipoprotein receptor activity and hydroxymethylglutaryl coenzyme A reductase activity in liver cells is due to inactivation of 25-hydroxycholesterol or 27-hydroxycholesterol by the action of cholesterol 7 alpha-hydroxylase.

摘要

研究发现,大鼠、猪和人的肝脏微粒体能够催化25-羟基胆固醇的7α-羟化反应。与胆固醇7α-羟化酶活性不同,大鼠肝脏中针对25-羟基胆固醇的7α-羟化酶活性不受消胆胺处理的刺激。用人类胆固醇7α-羟化酶的cDNA转染COS细胞后,该细胞对胆固醇表现出显著活性,但对25-羟基胆固醇则无活性。在从猪肝微粒体中纯化胆固醇7α-羟化酶的过程中,针对25-羟基胆固醇和27-羟基胆固醇的7α-羟化酶活性中约99%与针对胆固醇的7α-羟化酶活性明显分离。在胆固醇7α-羟化酶的部分纯化制剂中保留的少量25-羟基胆固醇7α-羟化酶活性不受胆固醇添加的抑制,这表明氧甾醇结合位点与胆固醇结合位点不同,推测是由于存在两种不同的酶。得出的结论是,大鼠、猪和人的肝脏中,胆固醇的7α-羟化反应和侧链氧化胆固醇的7α-羟化反应涉及不同的酶。用猪肝中氧甾醇7α-羟化酶的部分纯化组分进行的抑制实验结果与以下观点一致,即同一酶负责25-羟基胆固醇和27-羟基胆固醇的7α-羟化反应。有人提出,胆固醇7α-羟化酶可以优先利用氧甾醇,特别是25-羟基胆固醇作为底物,并以此方式使胆固醇稳态的重要生理调节因子失活。这样一种机制可以解释肝脏抵抗低密度脂蛋白受体下调的独特特性[杜兰德,S.,特拉维克,J.D.,& 戴维斯,R.A.(1993年)《生物化学杂志》267,22695 - 22698]。目前的结果不支持以下观点,即肝细胞中胆固醇7α-羟化酶活性、低密度脂蛋白受体活性和羟甲基戊二酰辅酶A还原酶活性之间的重要偶联是由于胆固醇7α-羟化酶的作用使25-羟基胆固醇或27-羟基胆固醇失活所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验